A group I intron precursor and ribozyme were cloned from the large subunit
rRNA of the human pathogen Candida albicans. Both the precursor and ribozym
e are functional as determined from in vitro assays. Comparisons of dissoci
ation constants for oligonucleotide binding to the ribozyme and to a hexanu
cleotide mimic of its internal guide sequence lead to a model for recogniti
on of the 5' exon substrate by this intron. In particular, tertiary contact
s with the P1 helix that help align the splice site include three 2'-hydrox
yl groups, a G.U pair that occurs at the intron's splice junction, and a G.
A pair. The free energy contribution that each interaction contributes to t
ertiary binding is determined. When the G.A pair is replaced with a G-C pai
r, tertiary interactions to 5' exon mimic 2'-hydroxyl groups are significan
tly weakened. When the G.A pair is replaced with a G.U pair, tertiary inter
actions are retained and binding is 10-fold tighter. These results expand o
ur knowledge of substrate recognition by group I introns, and also provide
a basis for rational design of oligonucleotide-based therapeutics for targe
ting group I introns by binding enhancement by tertiary interactions and su
icide inhibition strategies.